{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:22:39Z","timestamp":1781536959099,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","joms.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.joms.2025.01.008","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:28:53Z","timestamp":1737563333000},"page":"616-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monoclonal Antibodies and Small-Molecule Inhibitors Associated Osteonecrosis of Jaw: A Retrospective Pharmacovigilance Study"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-6503","authenticated-orcid":false,"given":"Kannan","family":"Sridharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5877-205X","authenticated-orcid":false,"given":"Gowri","family":"Sivaramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joms.2025.01.008_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/FAD.0000000000000007","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: Medical implications and dental complications","volume":"289","author":"Gowri","year":"2014","journal-title":"Adv Drug React Bull"},{"key":"10.1016\/j.joms.2025.01.008_bib2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American association of oral and maxillofacial surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2025.01.008_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.12968\/denu.2011.38.10.672","article-title":"A current update on osteonecrosis of the jaw and bisphosphonates","volume":"38","author":"Arrain","year":"2011","journal-title":"Dent Update"},{"key":"10.1016\/j.joms.2025.01.008_bib5","first-page":"981","article-title":"Denosumab-related osteonecrosis of the jaw","volume":"143","author":"Diz","year":"2012","journal-title":"JADA"},{"key":"10.1016\/j.joms.2025.01.008_bib6","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/j.bjoms.2021.03.006","article-title":"Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: Surgery or conservative therapy?","volume":"60","author":"Sacco","year":"2022","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2025.01.008_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.therap.2019.01.006","article-title":"Case-non-case studies: Principle, methods, bias and interpretation","volume":"74","author":"Faillie","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/j.joms.2025.01.008_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/life10080138","article-title":"Comparison of data mining methods for the signal detection of adverse drug events with a hierarchical structure in postmarketing surveillance","volume":"10","author":"Park","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.joms.2025.01.008_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.joms.2025.01.008_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.joms.2025.01.008_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s12886-024-03823-w","article-title":"Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: A retrospective focused pharmacovigilance study","volume":"24","author":"Sridharan","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.joms.2025.01.008_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91248-6","article-title":"Denosumab versus romosozumab for postmenopausal osteoporosis treatment","volume":"11","author":"Kobayakawa","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.joms.2025.01.008_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1188969","article-title":"Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis","volume":"14","author":"Hu","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.joms.2025.01.008_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/1060028020952764","article-title":"Romosozumab: A novel injectable sclerostin inhibitor with anabolic and antiresorptive effects for osteoporosis","volume":"55","author":"Nealy","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.joms.2025.01.008_bib16","series-title":"Lenvatinib","author":"Padda","year":"2024"},{"key":"10.1016\/j.joms.2025.01.008_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jcms.2018.12.014","article-title":"Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study","volume":"47","author":"Ristow","year":"2019","journal-title":"J Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.joms.2025.01.008_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.joms.2009.01.006","article-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","volume":"67","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.joms.2025.01.008_bib19","first-page":"3202","article-title":"Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: A case- and literature-based review","volume":"23","author":"Yamada","year":"2019","journal-title":"Clin Oral Inv"},{"key":"10.1016\/j.joms.2025.01.008_bib20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/jbmr.4472","article-title":"Risk of osteonecrosis of the jaw under denosumab compared to bisphosphonates in patients with osteoporosis","volume":"37","author":"Everts-Graber","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.joms.2025.01.008_bib21","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"}],"container-title":["Journal of Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239125000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278239125000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:24:01Z","timestamp":1746091441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278239125000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0278239125000552"],"URL":"https:\/\/doi.org\/10.1016\/j.joms.2025.01.008","relation":{},"ISSN":["0278-2391"],"issn-type":[{"value":"0278-2391","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal Antibodies and Small-Molecule Inhibitors Associated Osteonecrosis of Jaw: A Retrospective Pharmacovigilance Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joms.2025.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association of Oral and Maxillofacial Surgeons","name":"copyright","label":"Copyright"}]}}